SynBioBeta Speaker
Anthony Yu
Venture Architect
Appel Sauce Studios
YEAR
25
May 2025, SynBioBeta
Keynote Speaker
I am a venture architect at Appel Sauce Studios, developing multiple ventures through licensed IP. Our core technology platform enables sustained, controlled, and local delivery of all types of modalities, including cells and biologics--addressing key challenges in synthetic biology deployment. I have a PhD in Materials Science & Engineering with expertise in engineering biomaterials to enhance the performance of embedded therapeutic agents. Previously, I led R&D at a new venture Syntis Bio and before that I was in the formulation development team at Moderna.
SynBioBeta 2025 - Keynote
Reprogramming Drug Delivery: How Synthetic Biology is Unlocking the Next Generation of Therapeutics
Synthetic biology is redefining drug delivery, enabling breakthroughs in precision, targeting, and bioavailability. But what does synthetic biology really mean in this space? This panel brings together a diverse group of entrepreneurs and pharmaceutical leaders to discuss how they integrate synthetic biology to overcome key delivery challenges. Panelists will also explore the strategic questions of building a drug delivery company: Should they develop their own therapeutics or partner with pharma? How do they avoid commoditization and create lasting value? Join us for a dynamic discussion at the intersection of science and strategy in next-generation drug delivery.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Other Speakers
Other Speakers
2026
Event Updates